BICB (BioCube) Notes Receivable: $0.00 Mil (As of Jul. 2013)


What is BioCube Notes Receivable?

BioCube BICB -99.00% Notes Receivable is $0.00 Mil as of Jul. 2013.

BioCube's Notes Receivable for the quarter that ended in Jul. 2013 was $0.00 Mil.

BioCube Notes Receivable Historical Data

* Premium members only.

The historical data trend for BioCube's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioCube Notes Receivable Chart

BioCube Annual Data
Trend Jun06 Jun07 Jan08 Jan09 Jan11 Jan12 Jan13
Notes Receivable
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

BioCube Quarterly Data
Apr08 Jul08 Oct08 Jan09 Apr09 Oct09 Apr10 Jul10 Oct10 Jan11 Apr11 Jul11 Oct11 Jan12 Apr12 Jul12 Oct12 Jan13 Apr13 Jul13
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BioCube Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of $0.00 Mil mean?
BioCube (BICB) has a Notes Receivable of $0.00 Mil as of Jul. 2013. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on BioCube and its competitors.
Is BioCube's Notes Receivable too high?
BioCube's current Notes Receivable is $0.00 Mil.
How does BioCube's Notes Receivable compare to MBVXQ and GWSN?
BioCube's Notes Receivable of $0.00 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Diversified Financial Services company?
A good Notes Receivable depends on the Diversified Financial Services industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on BioCube and its competitors. BioCube's current Notes Receivable is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioCube stock overvalued right now?
BioCube (BICB) has a current Notes Receivable of $0.00 Mil. The current Notes Receivable is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For BioCube (BICB), the current Notes Receivable is $0.00 Mil as of Jul. 2013. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BioCube Business Description

Address 3060 West 3680 South, Suite 92, West Valley, UT, USA, 84119
BioCube Inc is a shell company.